Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
via Google News
The Latest on: Autism
- IMPD receives 1,300+ communication boards to help people with autismon August 3, 2022 at 7:57 pm
IMPD is getting more than 1,300 emergency communication boards. The boards serve a dual purpose. They will serve the officers as well as people who struggling with speech, so both can communicate with ...
- Autism early intervention services lacking in NJ, Rutgers sayson August 3, 2022 at 3:09 pm
A study found slightly less than half of more than 4,000 8-year-olds in Essex, Hudson, Ocean, and Union counties received proper services, but that's far fewer than really needed them especially when ...
- An autism-friendly outing to see Blue Man Group — without the stareson August 3, 2022 at 8:33 am
A Bethesda mom bought 500 tickets to a sensory-friendly show by the Blue Man Group at the Kennedy Center for theater-goers with autism, including her son.
- Most adults with autism can recognise facial emotions almost as well as those without the conditionon August 3, 2022 at 5:50 am
Difficulties with social communication and interaction are considered core features of autism. There is a common perception autistic people are poor at recognizing others' emotions and have little ...
- Children perform in Camp Wonderland theater show for children with autism spectrum disorderon August 3, 2022 at 2:01 am
Camp Wonderland offers youngsters with autism spectrum disorder training in art, music and drama over the summer. Here's a look at their performance.
- What Causes Autism? New Research Uncovers a Key Factor in Brain Developmenton August 2, 2022 at 9:23 pm
Researchers from Texas A&M College of Medicine have provided answers to important questions concerning how the neocortex develops, providing new information about the root causes of intellectual ...
- Blue Collar U downs Americana for Autism, takes home $1 million The Basketball Tournament titleon August 2, 2022 at 7:21 pm
Blue Collar U was on top of Americana for Autism from the opening tip, leading by as many as 22 points en route to an 89-67 victory in the TBT final Tuesday night and taking home $1 million in the ...
- 'Something doesn't add up': Family of 5-year-old Anthony Pearson take legal action after the child with autism and epilepsy was found dead at his daycareon August 2, 2022 at 4:01 pm
Right now, there is a push for clarity, into what led to a five-year-old boy's death at a south suburban daycare.Anthony Pearson died last month. CBS 2's Steven Graves is speaking to his mother who is ...
- Family of 5-year-old Anthony Pearson take legal action after the child with autism and epilepsy wason August 2, 2022 at 3:01 pm
CBS 2's Steve Graves reports there is a push for clarity into what led to a five year old boy's death at a south suburban daycare.
- Maternal genetics may confound studies of autism’s link to prenatal factorson August 2, 2022 at 4:00 am
Women who carry genetic variants tied to autism have an elevated chance of experiencing pregnancy-related events linked to the condition in their children.
via Bing News